secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK:        0001380106
Form:       8-K
Filed at:   2025-05-09T23:59:59+00:00
Accession:  0001380106-25-000099
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapid Micro Q1 revenue $7.2M (+28% YoY), gross margin turns positive 6%, net loss narrows to $11.3M
--------------------------------------------------------------------------------

- Product revenue $4.1M (+10%), service revenue $3.1M (+64%) driven by record validation activity; 3 new Growth Direct placements.
- Gross margin improved to 6% from -27% in Q1 2024; total operating expenses down 5% to $12.1M.
- Net loss per share $0.26 vs $0.31; cash & equivalents $42M with no debt outstanding.
- Global distribution agreement with MilliporeSigma (Merck KGaA) announced; joint training and planning underway.
- FY2025 guidance reaffirmed: total revenue at least $32M with 21-25 system placements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1380106/000138010625000099/0001380106-25-000099-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1380106/000138010625000099/rpid-20250509.htm
  HTML page:      https://secwatch.observer/filing/0001380106-25-000099

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer